BWA
HAE icon

BDO Wealth Advisors’s Haemonetics HAE Stock Holding History

BDO Wealth Advisors’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-32
Closed -$4K – 776
2019
Q4 		$4K Hold
32
– – ﹤0.01% 515
2019
Q3 		$4K Hold
32
– – ﹤0.01% 538
2019
Q2 		$4K Hold
32
– – ﹤0.01% 525
2019
Q1 		$3K Buy
+32
New +$2.91K ﹤0.01% 538
2018
Q1 		– Sell
-100
Closed -$6K – 588
2017
Q4 		$6K Buy
+100
New +$5.26K ﹤0.01% 364

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

BDO Wealth Advisors's HAE Position: Q1 2020 in Review

BDO Wealth Advisors sold out of Haemonetics (HAE) in Q1 2020, closing a stake of 32 shares — an estimated $4K sold.

BDO Wealth Advisors first reported a position in HAE in Q4 2017 and held it in 5 quarters. The position peaked at $6K in Q4 2017. 269 funds tracked by Wall St. Rank hold HAE as of Q1 2020.

  • BDO Wealth Advisors reported no remaining Haemonetics position as of Q1 2020 after selling out during the quarter.
  • BDO Wealth Advisors sold 32 Haemonetics shares in Q1 2020, an estimated $4K.
  • BDO Wealth Advisors first reported a position in Haemonetics in Q4 2017 and held it in 5 quarters.
  • BDO Wealth Advisors's Haemonetics position peaked at $6K in Q4 2017.
  • 269 funds tracked by Wall St. Rank held Haemonetics as of Q1 2020.

Based on BDO Wealth Advisors's 13F filing for Q1 2020, filed 15 May 2020.